uk-dgm MCQ (SBA): Discontinuation Review of Dementia Medications

Instant feedback + full explanation. One question, done properly.

ModerateDementia & Cognitive ImpairmentDiscontinuation Review of Dementia Medicationsuk-dgm

A 83-year-old woman with moderate Alzheimer's disease (MMSE 15/30) is reviewed in the memory clinic. She has been on Donepezil 10 mg and Memantine 20 mg for 2 years. Her MMSE has declined to 7/30 and she is now dependent for all personal care (Barthel Index 4/20). Her daughter asks whether it is time to stop the dementia medications. According to NICE NG97, what is the MOST appropriate advice?

Educational content. Not a substitute for clinical judgement or local policy.

uk-dgm MCQ: Discontinuation Review of Dementia Medications — Answer &